Neurometrix Inc
(NURO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,806 | -6,530 | -4,417 | -2,282 | -2,092 |
| Depreciation Amortization | 233 | 41 | -27 | 76 | 90 |
| Accounts receivable | 326 | 128 | -336 | 24 | -35 |
| Accounts payable and accrued liabilities | 148 | -153 | 84 | 142 | -583 |
| Other Working Capital | 570 | 6 | -1,713 | -1,233 | -1,058 |
| Other Operating Activity | -599 | 423 | 1,119 | 1,199 | 1,611 |
| Operating Cash Flow | $-7,128 | $-6,085 | $-5,289 | $-2,074 | $-2,067 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,348 | 1,340 | -16,789 | N/A | N/A |
| PPE Investments | N/A | -184 | -23 | -132 | N/A |
| Investing Cash Flow | $5,348 | $1,156 | $-16,812 | $-132 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,476 | 2,325 | 3,864 | 19,551 | 4,167 |
| Financing Cash Flow | $1,476 | $2,325 | $3,864 | $19,551 | $4,167 |
| Beginning Cash Position | 1,732 | 4,335 | 22,572 | 5,226 | 3,126 |
| End Cash Position | 1,428 | 1,732 | 4,335 | 22,572 | 5,226 |
| Net Cash Flow | $-304 | $-2,603 | $-18,237 | $17,346 | $2,100 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,128 | -6,085 | -5,289 | -2,074 | -2,067 |
| Capital Expenditure | N/A | -184 | -23 | -132 | N/A |
| Free Cash Flow | -7,128 | -6,268 | -5,313 | -2,205 | -2,067 |